Manish Gupta

[Matt Johansen @mattjay]

🧵 THREAD: A federal whistleblower just dropped one of the most disturbing cybersecurity disclosures I’ve ever read.

He's saying DOGE came in, data went out, and Russians started attempting logins with new valid DOGE passwords

Media's coverage wasn't detailed enough so I dug into his testimony:

[Manish Gupta @TrueManzil]

@elonmusk Try reading the article instead of taking the obvious bait. It turns out education and hard work can actually lead to career success.

[Manish Gupta @TrueManzil]

@therabbithole @QuiverQuant This chart completely ignores the billions that went into pro-Trump super pacs, where Trump far outpaced Democrats.

[Manish Gupta @TrueManzil]

@jfais20 Thanks @jfais20. I hope it's ok if I share the full post--just to avoid losing any context. 🙏

[Manish Gupta @TrueManzil]

@jfais20 Thanks @jfais20. I hope it's ok if I share the full post--just to avoid losing any context. 🙏

[Manish Gupta @TrueManzil]

@TheFortuneTell5 Nice list, I own all four.

[Manish Gupta @TrueManzil]

@jfais20 $ADAG Unfortunately, updated data failed to impress. Out for now--but will keep watching.

[Manish Gupta @TrueManzil]

@InconvenientTr5 Actually, no. I worked my way through college with part time jobs, saved up to start my first business, sold it, used the money to start two more, and sold those. And you?

[Manish Gupta @TrueManzil]

@ThinkFreedm Boy, you sure drank the cool-aid. Good luck to you. And please do short some more shares. 👍

[Manish Gupta @TrueManzil]

$CHRS Nice win with tori approved in all lines of therapy for NPC. With J-Code in place and leveraging existing Udencya sales org, I see no reason tori shouldn't quickly become SoC. Long CHRS.

[Manish Gupta @TrueManzil]

@PersimmonTI $ROIV The sell-off is on very high volume, so it's a bit of a head-scratcher. My only guess is maybe there's something in the details we don't know. I do wonder if there was significant cash sitting on Televant's balance sheet.

[Manish Gupta @TrueManzil]

$IBRX Resubmits BLA for anktiva in both BCG-Unresponsive *and* BCG-Naive NMIBC. Unless I'm mistaken, this would make them a 1L option in NMIBC. Received CRL earlier this year citing CMC issues. Long IBRX.

[Manish Gupta @TrueManzil]

$MREO Nice. https://t.co/7Li2FRgtHi

[Manish Gupta @TrueManzil]

$MREO (L) Partner Ultragenyx presenting updated data for setrusumab P2/P3 at ASBMR today followed by an analyst day webcast on Monday. Hoping to see positive fracture data in the 5-26yo subset.

[Manish Gupta @TrueManzil]

$MIST (L) $91M EV, $89M cash, access to $75M in non-dilutive royalty funding, and LT debt of $48M is convertible. 8.5% insider ownership and 72% institutional ownership. Expect NDA filing in PSVT this month and P2 results in AFib-RVR to be presented at AHA conference in November.

[Manish Gupta @TrueManzil]

@WallStreetTitan @jfais20 2/ We really need a CC to clarify what the FDA wants, how this impacts their rollout into trauma setting, and cash runway. Recall earlier management's plan was to wait for GO approval before wider launch into trauma centers and international.

[Manish Gupta @TrueManzil]

@WallStreetTitan @jfais20 1/ ($RCEL Long) Agree long term thesis is intact. More risk near-term, though, until we have a better idea what the FDA wants. I've watched the disaggregation videos and I think GO is actually quite important to drive widespread adoption towards SoC.

[Manish Gupta @TrueManzil]

@Alex__Pitti $RCEL (L) In their 8-K filing, management is now estimating approval by Mid-2024. But IMO it's hard to know anything for certain until we get more information. I expect (hope) management will schedule a CC for this week or next.

[Manish Gupta @TrueManzil]

$RCEL IMO today's update adds significant risk in the near-to-mid term. In their 8-K filing, management did not rule out the need for a pre-approval study, so caution is probably a good idea until we have more information.

[Manish Gupta @TrueManzil]

Re-entered $EDAP on recent weakness. $EDAP $STXS $RCEL all highly de-risked and fit perfectly into my biotech/medtech robotics & automation theme. Long all three.